[1] Denny L, Quinn M, Hacker N. FIGO Cancer Report 2012[J]. Int J Gynaecol Obstet, 2012,119(Suppl 2):S89. [2] Greer BE, Koh WJ, Abu-Rustum N, et al. Uterine Neoplasms. Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2009,7(5):498-531. [3] Zivanovic O, Carter J, Kauff ND, et al. A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer[J]. Gynecol Oncol, 2009,115(3):504-509. [4] Sorosky JI. Endometrial cancer[J]. Obstet Gynecol, 2008,111(2 Pt 1):436-447. [5] Mao Y, Wan X, Chen Y, et al. Outcomes of conservative therapy for young women with early endometrial adenocarcinoma[J]. Fertil Steril, 2010,93(1):283-285. [6] Kim MK, Yoon BS, Park H, et al. Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women: pilot study[J]. Int J Gynecol Cancer, 2011,21(4):673-677. [7] Yamazawa K, Hirai M, Fujito A, et al. Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer[J]. Hum Reprod, 2007,22(7):1953-1958. [8] Frumovitz M, Gershenson DM. Fertility-sparing therapy for young women with endometrial cancer[J]. Expert Rev Anticancer Ther, 2006,6(1):27-32. [9] Benshushan A. Endometrial adenocarcinoma in young patients: evaluation and fertility-preserving treatment[J]. Eur J Obstet Gynecol Reprod Biol, 2004,117(2):132-137. [10] Yang YC, Wu CC, Chen CP, et al. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer[J]. Gynecol Oncol, 2005,99(2):287-293. [11] Niwa K, Tagami K, Lian Z, et al. Outcome of fertility-preserving treatment in young women with endometrial carcinomas[J]. BJOG, 2005,112(3):317-320. [12] Lavie O. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer[J]. Obstet Gynecol, 2004,103(5 Pt 1):997-8; author reply 980. [13] Gotlieb WH, Beiner ME, Shalmon B, et al. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer[J]. Obstet Gynecol, 2003,102(4):718-725. [14] Shah MM, Wright JD. Management of endometrial cancer in young women[J]. Clin Obstet Gynecol, 2011,54(2):219-225. [15] Erkanli S, Ayhan A. Fertility-sparing therapy in young women with endometrial cancer: 2010 update[J]. Int J Gynecol Cancer, 2010,20(7):1170-1187. |